LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 101 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,440 | -65.1% | 51,220 | -58.2% | 0.00% | – |
| Q2 2023 | $172,980 | +917.5% | 122,681 | +1027.0% | 0.00% | – |
| Q2 2022 | $17,000 | -80.0% | 10,886 | -80.4% | 0.00% | – |
| Q1 2022 | $85,000 | -86.4% | 55,471 | -78.2% | 0.00% | -100.0% |
| Q4 2021 | $624,000 | +32.2% | 254,817 | +35.9% | 0.00% | – |
| Q3 2021 | $472,000 | +555.6% | 187,486 | +643.4% | 0.00% | – |
| Q2 2021 | $72,000 | +620.0% | 25,219 | +143.6% | 0.00% | – |
| Q3 2019 | $10,000 | – | 10,354 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 4,735,990 | $8,335,000 | 3.63% |
| BROADWOOD CAPITAL INC | 34,005,379 | $59,849,000 | 3.55% |
| Prescott General Partners LLC | 1,851,851 | $3,259,000 | 0.14% |
| Strategic Wealth Investment Group, LLC | 66,917 | $118,000 | 0.07% |
| Laidlaw Wealth Management LLC | 170,658 | $300,000 | 0.06% |
| Humankind Investments LLC | 26,737 | $47,000 | 0.05% |
| DAFNA Capital Management LLC | 80,000 | $141,000 | 0.04% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $79,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 680,839 | $1,198,000 | 0.02% |
| Allegheny Financial Group LTD | 20,000 | $35,000 | 0.02% |